Shawn Kwatra, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Abbvie, Amgen, Arcutis Biotherapeutics, Aslan Pharmaceuticals, Bristol Myers Squibb, Cara Therapeutics, Castle Biosciences, Dermavant, Galderma, Incyte Corporation, Johnson & Johnson, Leo Pharma, Novartis Pharmaceuticals Corporation, Pfizer, Regeneron
    Date added:
    11/19/2024
    Date updated:
    11/19/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Sanofi
    Date added:
    11/19/2024
    Date updated:
    11/19/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Galderma, Incyte, Pfizer, and Sanofi
    Topic:
    served as an investigator
    Date added:
    11/19/2024
    Date updated:
    11/19/2024
Return to Dec. 7, 2024 - Dr. Herbert Golomb Washington, D.C. Dermatological Society Clinical Conference